Osaka Kawasaki Rehabilitation University

Message

  1. TOP
  2. Message

Message from the Chief Director of the University

Tatsuhito Kawasaki, M.D., Ph.D.

President,
Medical Corporation Kawasakikai Superintendent,
Mizuma Hospital President,
Social Medical Corporation Kenjinkai Dean,
Kawasaki Nursing College

Nurture Medical Professionals with a Rich Sense of Humanity Based on the Founding Spirit of "Dreams and Great Compassion”

Osaka Kawasaki Rehabilitation University (OKRU) was founded in 2006 with the founding spirit of "Dreams and Great Compassion " as its guiding philosophy. Our goal is to nurture medical professionals who have dreams and aspirations, and who are capable of accepting and grieving for pain, sorrow, and suffering of others, and who are equipped with human qualities.
In rapidly aging society, active rehabilitation in terms of bot h treatment and care is becoming increasingly important, and the demand for physical therapists, occupational therapists, and speech-language therapists is increasing, so we believe it is n ecessary to train high quality medical professionals in this field. In turn, we hope to contribute our knowledge, skills, and research to the improvement of health, medical care, and welfare, and to give b ack to society so that we can heal the sick, the disabled, and those who support them.
We ha ve e stablished a n e nvironment wh ere st udents c an l earn the three a reas essential for rehabilitation in the lush greenery of Mizuma Area, and we have created an environment for learning team medicine in cooperation with the Kawasaki Group, core hosp itals, and a wide range of clinical training facilities. We hope that our students will become medi cal professionals who can heal patients not only technically but also spiritually.

Message from the University President

Masatoshi Takeda, M.D., Ph.D.

Dean/ Director, Cognitive Reserve Research Center
OKRU; Aiming for the Goal of Realizing Useful Rehabilitation
Needed from the Society by Fostering
Excellent and Kind-hearted Therapists

Osaka Kawasaki Rehabilitation University (OKRU) is educating three nationally-qualified rehabilitation professionals; physical therapists, occupational therapists, and speech-language pathologists, one of the four educational institutions in Osaka Prefecture that train all three professions.
The university was established in 2006 as the first university i n Japan to bear the name of "rehabilitation," and has been sending out rehabilitation specialists for more than 20 years since 1997.
Many of our graduates are active as rehabilitation professionals at nearby medical, nursing, and welfare facilities in Osaka and Wakayama Prefecture. As society ages, the need for rehabilitation professionals will continue to increase. We hope to continue to nurture "exce llent and kind-hearted rehabilitation therapists" who can be close to and support people with disabilities, including the elderly.
OKRU is a small university specialized to rehabilitation science, all faculty members work with the goal of passing down the message on the importance of rehabilitation and the latest knowledge and techniques to the younger generation. I hope that many young pe ople will study rehabilitation and contribute to society.

BIOSKETCH of Prof. Masatoshi Takeda

  • 1983

    Graduated from Graduate School of Medicine, Osaka University, MD, PhD.

  • 1984

    Research Assistant, Department of Psychiatry, Osaka University

  • 1985-1987

    Research Fellow at University of Florida and Baylor College of Medicine, USA

  • 1991

    Assistant Professor, Department of Psychiatry, Osaka University

  • 1996

    Chairman Professor, Department of Psychiatry, Osaka University

  • 2015

    President, Aino University

  • 2018

    Director, Cognitive Reserve Research Center, OKRU

  • 2020

    President, OKRU

Prof. Takeda, MD, PhD, served as the chairman professor of psyc hiatry, Osaka University, one of the most influential and second oldest psychiatry department in Japan for 19 years since 1996 to 2015. As the professor emeritus of Osaka University, he is now working a s the President and Director of Cognitive Reserve Research Center of Osaka Kawasaki Rehabilitation University.
He has been engaged with biological psychiatry research at Osaka University, University of Florida, and Baylor Medical School in USA. With his background of neurochemi stry, molecular genetics, and cell biology, his research covers from basic to clinical psychiatry of major psychiatric disorders including dementia, He has published over 400 original papers in English, and over 900 papers in psychogeriatrics, biological psychiatry, and clinical psychiatry. Recent research interest covers molecular biology of Alzheimer’ s disease, clinicopathology of schizophrenia, cognitive impairment in psychiatric disorders including cognitive reserve of the elderly.
Prof. Takeda served as the President of Japanese Society of Psy chiatry and Neurology (JSPN) for five years from 2012 to 2016, President of Japanese Society of Biological Psychiatry (JSBP) for six years before he has become the President of World Federation of Societies of Biological Psychiatry (WFSBP) in 2015. He also served as the president of International Psychogeriatric Association (IPA) from 2008 to 2011.
He was involved with the journals as the Editor-in-Chief of man y journals, including Psychogeriatrics (official journal of Japanese Psychogeriatric Society), Psychiatry and Clinical Neurosciences (official journal of JSPN), Japanese Journal of Psychiatry and Neurology, Dementia Japan (official journal of Japan Society of Dementia Research), Cognition and Dementia, and Schizophrenia Frontier.

  • Presenilin-1 mutations downregulate the signaling pathway of the unfolded-protein response． Nature Cell Biology , 1(8) : 479-485, 1999
  • Medial prefrontal cortex generates frontal midline theta rhythm．Neuroreport , 10(4) : 675-679, 1999
  • Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide．Journal of Biolo gical Chemistry 277(47) :44754-44759, 2002
  • Presenilins mediate a dual intramembranous γ‐secretase cleavage of Notch‐1．The EMBO journal , 21(20) : 5408-5416, 2002
  • A molecular chaperone inducer protects neurons from ER stress1．Cell Death & Differentiation, 15(2) : 364-375 , 2008
  • Disturbed activation of endoplasmic reticulum stress transducer s by familial Alzheimer's disease-linked presenilin-1 mutations．Journal of Biological Chemistry, 276(46) : 43446-43454 ,2001
  • A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 o n endoplasmic reticulum and reduces their anti-apoptotic activity． Oncogene , 19(50) : 5736-5742, 2000
  • The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease．International Journal of Geriatric Psychiatry , 14(1) : 3-47 , 1999
  • The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β -amyloid production and tau phosphorylation in Alzheimer diseas e．Human Molecular Genetics ,16(1) : 15-23 , 2006